Response to "Lupus anticoagulant is frequent in patients with Covid-19" (JTH-2020-00483).
作者信息
Tang Ning
机构信息
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
出版信息
J Thromb Haemost. 2020 Aug;18(8):2065-2066. doi: 10.1111/jth.14890. Epub 2020 Jun 25.
Abstract
摘要
相似文献
1
Response to "Lupus anticoagulant is frequent in patients with Covid-19" (JTH-2020-00483).对《狼疮抗凝物在新冠病毒病患者中常见》（JTH - 2020 - 00483）的回应
J Thromb Haemost. 2020 Aug;18(8):2065-2066. doi: 10.1111/jth.14890. Epub 2020 Jun 25.
2
Lupus Anticoagulant in Patients with Covid-19. Reply.新冠病毒肺炎患者中的狼疮抗凝物。回复。
N Engl J Med. 2020 Nov 5;383(19):1893-1894. doi: 10.1056/NEJMc2027508. Epub 2020 Oct 23.
3
Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19).2019年冠状病毒病（COVID-19）患者狼疮抗凝物阳性的评估
JAMA Netw Open. 2020 Aug 3;3(8):e2017539. doi: 10.1001/jamanetworkopen.2020.17539.
4
Acute Ischemic Stroke in a Lupus Anticoagulant-Positive Woman With COVID-19.一名狼疮抗凝物阳性的新冠病毒肺炎女性患者发生急性缺血性卒中
J Clin Rheumatol. 2020 Sep;26(6):236-237. doi: 10.1097/RHU.0000000000001565.
5
Lupus anticoagulant is frequent in patients with Covid-19.狼疮抗凝物在新冠病毒肺炎患者中很常见。
J Thromb Haemost. 2020 Aug;18(8):2064-2065. doi: 10.1111/jth.14867. Epub 2020 May 11.
6
Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism.抗磷脂抗体在重症 COVID-19 肺炎合并静脉血栓栓塞患者中并不升高。
Thromb Res. 2020 Aug;192:113-115. doi: 10.1016/j.thromres.2020.05.017. Epub 2020 May 15.
7
Lupus Anticoagulant in Patients with Covid-19.新冠病毒肺炎患者中的狼疮抗凝物
N Engl J Med. 2020 Nov 5;383(19):1893. doi: 10.1056/NEJMc2027508. Epub 2020 Oct 23.
8
COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?新型冠状病毒肺炎与缺血性卒中：我们是否应该系统性地检测狼疮抗凝物和抗磷脂抗体？
Rev Neurol (Paris). 2020 Jun;176(6):505-506. doi: 10.1016/j.neurol.2020.05.001. Epub 2020 May 8.
9
Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.新冠病毒肺炎患者的狼疮抗凝物与异常凝血检测
N Engl J Med. 2020 Jul 16;383(3):288-290. doi: 10.1056/NEJMc2013656. Epub 2020 May 5.
10
The association between D-dimers in COVID-19 patients and mortality remains beset of uncertainties.新冠病毒肺炎患者中D-二聚体与死亡率之间的关联仍充满不确定性。
J Thromb Haemost. 2020 Aug;18(8):2068-2070. doi: 10.1111/jth.14941.
引用本文的文献
1
Platelet activation and partial desensitization are associated with viral xenophagy in patients with severe COVID-19.血小板活化和部分脱敏与重症 COVID-19 患者的病毒异噬作用有关。
Blood Adv. 2022 Jul 12;6(13):3884-3898. doi: 10.1182/bloodadvances.2022007143.
2
Pathophysiology of COVID-19: Critical Role of Hemostasis.新型冠状病毒肺炎的病理生理学：止血的关键作用。
Front Cell Infect Microbiol. 2022 Jun 3;12:896972. doi: 10.3389/fcimb.2022.896972. eCollection 2022.
3
Integrated analysis of transcriptomic data reveals the platelet response in COVID-19 disease.整合转录组数据分析揭示 COVID-19 疾病中的血小板反应。
Sci Rep. 2022 Apr 27;12(1):6851. doi: 10.1038/s41598-022-10516-1.
4
Management of hypertension in patients with COVID-19: Implication of angiotensin-converting enzyme 2.2019冠状病毒病患者的高血压管理：血管紧张素转换酶2的影响
Cardiol Plus. 2021 Oct 1;6(4):210-217. doi: 10.4103/2470-7511.334397. Epub 2021 Dec 30.
5
A retrospective study on the prevalence of anti-phospholipid antibodies, thrombotic events and cutaneous signs of vasculopathy in 173 hospitalized COVID-19 patients.一项关于 173 例住院 COVID-19 患者抗磷脂抗体、血栓事件和血管病变皮肤表现患病率的回顾性研究。
Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211042115. doi: 10.1177/20587384211042115.
6
Incidence of lupus anticoagulant in hospitalized covid-19 patients.住院COVID-19患者中狼疮抗凝物的发生率。
Am J Blood Res. 2021 Jun 15;11(3):317-324. eCollection 2021.
7
COVID-19 and Hypertension: The What, the Why, and the How.新型冠状病毒肺炎与高血压：是什么、为什么以及如何应对。
Front Physiol. 2021 May 3;12:665064. doi: 10.3389/fphys.2021.665064. eCollection 2021.
8
Systemic and organ-specific immune-related manifestations of COVID-19.COVID-19 的全身性和器官特异性免疫相关表现。
Nat Rev Rheumatol. 2021 Jun;17(6):315-332. doi: 10.1038/s41584-021-00608-z. Epub 2021 Apr 26.
9
Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients.危重症 COVID-19 阳性和阴性患者中的抗心磷脂抗体和其他抗磷脂抗体。
Ann Rheum Dis. 2021 Sep;80(9):1236-1240. doi: 10.1136/annrheumdis-2021-220206. Epub 2021 Apr 26.
10
The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.在 COVID-19 期间发生的慢性炎症和自身免疫性疾病的 JANUS-系统综述文献。
J Autoimmun. 2021 Feb;117:102592. doi: 10.1016/j.jaut.2020.102592. Epub 2020 Dec 14.
本文引用的文献
1
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19.新型冠状病毒肺炎患者的凝血障碍与抗磷脂抗体
N Engl J Med. 2020 Apr 23;382(17):e38. doi: 10.1056/NEJMc2007575. Epub 2020 Apr 8.
2
False-positive lupus anticoagulant in patients receiving rivaroxaban: 24 h since the last dose are needed to exclude antiphospholipid syndrome.接受利伐沙班治疗的患者出现假阳性狼疮抗凝物：需在末次给药24小时后才能排除抗磷脂综合征。
Blood Coagul Fibrinolysis. 2015 Jun;26(4):473-5. doi: 10.1097/MBC.0000000000000235.
3
Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.狼疮抗凝物检测指南更新。国际血栓与止血学会科学标准化委员会狼疮抗凝物/抗磷脂抗体子委员会。
J Thromb Haemost. 2009 Oct;7(10):1737-40. doi: 10.1111/j.1538-7836.2009.03555.x. Epub 2009 Jul 17.
4
Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.关于弥散性血管内凝血的定义、临床及实验室标准和评分系统
Thromb Haemost. 2001 Nov;86(5):1327-30.
Zotero 插件